1. Home
  2. ZCMD vs TNON Comparison

ZCMD vs TNON Comparison

Compare ZCMD & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zhongchao Inc.

ZCMD

Zhongchao Inc.

N/A

Current Price

$2.03

Market Cap

6.9M

Sector

Real Estate

ML Signal

N/A

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.80

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZCMD
TNON
Founded
2012
2012
Country
China
United States
Employees
N/A
27
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
7.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
ZCMD
TNON
Price
$2.03
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.5K
86.5K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$65.95
Revenue Next Year
N/A
$50.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.64
52 Week High
$2.10
$2.48

Technical Indicators

Market Signals
Indicator
ZCMD
TNON
Relative Strength Index (RSI) 65.02 53.00
Support Level $1.09 $0.66
Resistance Level N/A $0.88
Average True Range (ATR) 0.13 0.04
MACD -0.02 0.01
Stochastic Oscillator 82.05 64.66

Price Performance

Historical Comparison
ZCMD
TNON

About ZCMD Zhongchao Inc.

ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: